Editorial
|
|
|
|
|
Anticancer drugs are a case in point
|
|
|
|
Marketing Authorisations
|
|
|
|
|
Type 2 diabetes: no rush to use this drug
|
|
|
|
|
|
|
|
|
|
No progress in plaque psoriasis or psoriatic arthritis
|
|
|
|
|
|
|
|
Adverse Effects
|
|
|
|
|
Another reason not to use these drugs
|
|
|
|
|
|
|
|
|
|
|
|
Even in the absence of any interacting drugs
|
|
|
|
|
|
|
|
|
|
Potentially incapacitating
|
|
|
|
Reviews
|
|
|
|
|
Guide to first-choice treatments
|
|
|
|
|
|
|
|
|
|
No reduction in mortality or incidence of pneumonia
|
|
|
|
|
|
|
|
|
|
Uncertain benefits: more trials are needed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The finances of Association Mieux Prescrire: 2015 Prescrire annual report
|
|
|
|
|
|